The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

Drb1  -  dopamine receptor binding 1

Mus musculus

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Drb1


Psychiatry related information on Drb1


High impact information on Drb1


Chemical compound and disease context of Drb1


Biological context of Drb1


Associations of Drb1 with chemical compounds


  1. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. Kanes, S.J., Hitzemann, B.A., Hitzemann, R.J. J. Pharmacol. Exp. Ther. (1993) [Pubmed]
  2. D1 dopamine receptors are not expressed in human melanoma. Böni, R., Lichtensteiger, W., Steinert, H.C., Böni, R.A., Früh, H., Dummer, R., Hartmann, D.G., Laine, E., Burg, G. Melanoma Res. (1997) [Pubmed]
  3. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Suhara, T., Nakayama, K., Inoue, O., Fukuda, H., Shimizu, M., Mori, A., Tateno, Y. Psychopharmacology (Berl.) (1992) [Pubmed]
  4. Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in mu-opioid receptor knockout mice. Tien, L.T., Park, Y., Fan, L.W., Ma, T., Loh, H.H., Ho, I.K. Brain Res. Bull. (2003) [Pubmed]
  5. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites. Boehme, R.E., Ciaranello, R.D. Proc. Natl. Acad. Sci. U.S.A. (1981) [Pubmed]
  6. Mapping the genes for haloperidol-induced catalepsy. Kanes, S., Dains, K., Cipp, L., Gatley, J., Hitzemann, B., Rasmussen, E., Sanderson, S., Silverman, M., Hitzemann, R. J. Pharmacol. Exp. Ther. (1996) [Pubmed]
  7. The effect of benzodiazepines on the binding of [3H]SCH 23390 in vivo. Inoue, O., Kobayashi, K., Sakiyama, Y., Suzuki, T. Neuropharmacology (1992) [Pubmed]
  8. Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment. Hyttel, J. Psychopharmacology (Berl.) (1978) [Pubmed]
  9. 2-substituted tetralin derivatives as conformationally restricted butyrophenone analogs. Chan, C.C., Farmer, P.S., McKenzie, G., Robertson, H. Die Pharmazie. (1987) [Pubmed]
  10. Effects of rolipram on in vivo dopamine receptor binding. Hosoi, R., Ishikawa, M., Kobayashi, K., Gee, A., Yamaguchi, M., Inoue, O. Journal of neural transmission (Vienna, Austria : 1996) (2002) [Pubmed]
  11. Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution. Saji, H., Tokui, T., Nakatsuka, I., Saiga, A., Magata, Y., Shiba, K., Yoshitake, A., Yokoyama, A. Chem. Pharm. Bull. (1992) [Pubmed]
  12. Prevention of fluphenazine-induced changes in dopaminergic and muscarinic receptors by lithium. Gianutsos, G., Friedman, E. Pharmacol. Biochem. Behav. (1987) [Pubmed]
WikiGenes - Universities